Sculptor Capital’s Allergan plc AGN Stock Holding History

Sculptor Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,157,400	Closed	-$237M	–	256
2017 Q3	$237M	Buy	1,157,400 +85,500	+8%	+$19.9M	1.15%	17
2017 Q2	$261M	Buy	1,071,900 +562,100	+110%	+$132M	1.38%	14
2017 Q1	$122M	Buy	509,800 +373,400	+274%	+$87M	0.69%	42
2016 Q4	$28.6M	Buy	136,400 +66,100	+94%	+$13.7M	0.2%	85
2016 Q3	$16.2M	Buy	+70,300	New	+$17.2M	0.09%	121
2016 Q2	–	Sell	-23,100	Closed	-$6.19M	–	437
2016 Q1	$6.19M	Buy	+23,100	New	+$6.61M	0.03%	230
2014 Q2	–	Sell	-177,100	Closed	-$36.5M	–	846
2014 Q1	$36.5M	Buy	+177,100	New	+$35.1M	0.12%	174

Other funds holding AGN

Ashburton (Jersey) St Helier, Jersey $227M AUM

Cerebellum San Francisco, California $21.5M AUM

Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return

JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Sculptor Capital's AGN Position: Q2 2020 in Review

Sculptor Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 234,328 shares — an estimated $41.5M sold.

Sculptor Capital first reported a position in AGN in Q2 2013 and held it in 16 quarters. The position peaked at $1.17B in Q3 2014. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

Sculptor Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
Sculptor Capital sold 234,328 Allergan plc shares in Q2 2020, an estimated $41.5M.
Sculptor Capital first reported a position in Allergan plc in Q2 2013 and held it in 16 quarters.
Sculptor Capital's Allergan plc position peaked at $1.17B in Q3 2014.
7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Sculptor Capital's 13F filing for Q2 2020, filed 14 Aug 2020.